ROSENWALD LINDSAY A MD
Transactions
50
Companies
26
Filings
16
CIK
0000941841
Recent Transactions
- Award
- Award
- Disposition from Tender
- Award
- Award
- Award
- Award
- Award
- Purchase
Warrants to Purchase Common Stock
2024-09-23$0.13/sh+763,359→ 763,359 total - Purchase
Common stock, par value $0.001
2024-09-23$1.84/sh+763,359→ 3,657,264 total - Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-11$7.48/sh+5,000→ 127,500 total - Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-09$7.39/sh+5,000→ 122,500 total - Award
- Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-08$7.35/sh+5,000→ 117,500 total - Purchase
- Purchase
- Award
- Award
- Purchase
- Purchase
- Purchase
- Award
- Purchase
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-11-14$1.70/sh+1,567,515→ 2,597,440 total - Purchase
COMMON STOCK, PAR VALUE $0.001
2023-09-26$0.28/sh+100,000→ 15,449,091 total - Purchase
- PurchaseJourney Medical Corp$DERM
Common Stock, par value $0.0001 per share
2023-09-06$2.23/sh+100,000→ 114,245 total - Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2023-08-18$9.34/sh+10,000→ 112,500 total - Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2023-08-17$11.75/sh+10,000→ 102,500 total - Award
- Award
- Award
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-02-10$0.83/sh+2,395,209→ 15,349,091 total - Award
- Purchase
COMMON STOCK, PAR VALUE $0.001
2022-12-01$0.68/sh+100,000→ 11,730,324 total - Purchase
- Purchase
COMMON STOCK, PAR VALUE $0.001
2022-10-21$0.69/sh+100,000→ 11,625,324 total - Purchase
- Award
- Award
- Award
- Award
- Purchase
- Award
- Award
- Other
- Other
- Award
- Award
- Award
Companies
26ARCTIC ACQUISITION CORP.
10% Owner
- $ATXI
AVENUE THERAPEUTICS, INC.
Director
BRISTOL BAY SCIENCES, INC.
10% Owner
Checkpoint Therapeutics, Inc.
Director
CHEM RX CORP
Director, Chairman of the Board
CHITINA SCIENCES, INC.
10% Owner
CORDOVA SCIENCES, INC.
10% Owner
Cougar Biotechnology, Inc.
Director, 10% Owner
CYPRESS BIOSCIENCE INC
10% Owner
CytRx Oncology Corp
10% Owner
- $FBIO
Fortress Biotech, Inc.
Director
GENTA INC DE/
10% Owner
JAVELIN PHARMACEUTICALS, INC
10% Owner
- $DERM
Journey Medical Corp
Director
KANAI SCIENCES, INC.
10% Owner
KERYX BIOPHARMACEUTICALS INC
Director, 10% Owner
KODIAK SCIENCES, INC.
10% Owner
- $MBIO
MUSTANG BIO, INC.
Director
NATIONAL HOLDINGS CORP
10% Owner
NORTON SOUND ACQUISITION CORP.
10% Owner
NOVADEL PHARMA INC
10% Owner
Origo Acquisition Corp
Director, Co-Chairman and CEO, 10% Owner
SEWARD SCIENCES, INC.
10% Owner
SITKA SCIENCES, INC.
10% Owner
- $TGTX
TG THERAPEUTICS, INC.
10% Owner
VELCERA, INC.
10% Owner
Recent Filings
16- 4
ROSENWALD LINDSAY A MD
Aug 7, 2025
- 4
ROSENWALD LINDSAY A MD
Jul 7, 2025
- 4
ROSENWALD LINDSAY A MD
May 30, 2025
- 4
ROSENWALD LINDSAY A MD
Jan 3, 2025
- 4
ROSENWALD LINDSAY A MD
Dec 17, 2024
- 4
ROSENWALD LINDSAY A MD
Sep 25, 2024
- 4
ROSENWALD LINDSAY A MD
Sep 25, 2024
- 4
ROSENWALD LINDSAY A MD
Jul 15, 2024
- 4
ROSENWALD LINDSAY A MD
Jul 11, 2024
- 4
ROSENWALD LINDSAY A MD
Jul 10, 2024
- 4
ROSENWALD LINDSAY A MD
Jul 10, 2024
- 4
ROSENWALD LINDSAY A MD
Jul 1, 2024
- 4
ROSENWALD LINDSAY A MD
May 20, 2024
- 4
ROSENWALD LINDSAY A MD
May 16, 2024
- 4
ROSENWALD LINDSAY A MD
Mar 27, 2024
- 4
ROSENWALD LINDSAY A MD
Mar 25, 2024
Address
C/O CORONADO BIOSCIENCES, INC. 15 NEW ENGLAND EXECUTIVE PARK
BURLINGTON, MA, 01803